Clinical Trial: Intestinal Fatty Acid Binding Protein in Very Low Birth Weight Infants With Meconium Obstruction

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: The Clinical Utility of Urine Intestinal Fatty Acid Binding Protein in the Management of Very Low Birth Weight Infants With Meconium Obstruction

Brief Summary: Urinary intestinal fatty acid binding protein (i-FABP), a marker of intestinal mucosal cell damage, has recently been proposed as a clinically useful measure in the early detection of necrotizing enterocolitis (NEC). However, there are no data on urinary i-FABP in meconium obstruction of prematurity (MOP). This study aimed to evaluate urinary i-FABP in MOP patient as a marker for early detection.